CD30 Ligand/TNFSF8 Rekombinanter Antikörper

CD30 Ligand/TNFSF8 Rekombinant Antikörper für FC

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

FC

Konjugation

Unkonjugiert

CloneNo.

241831D9

Kat-Nr. : 98253-1-PBS

Synonyme

TNFSF 8, CD30 L, TNFSF8, 241831D9, CD30LG



Geprüfte Anwendungen

Produktinformation

98253-1-PBS bindet in FC CD30 Ligand/TNFSF8 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen Rekombinantes Protein
Vollständiger Name tumor necrosis factor (ligand) superfamily, member 8
Berechnetes Molekulargewicht 234 aa, 26 kDa
GenBank-ZugangsnummerBC093630
Gene symbol TNFSF8
Gene ID (NCBI) 944
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein A purfication
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C.

Hintergrundinformationen

CD30 Ligand (CD30L), also named as TNFSF8 or CD153, is a type II transmembrane protein that belongs to the tumor necrosis factor (TNF) superfamily (PMID: 8391931). It is expressed on the surface of activated T cells, B cells, monocytes, macrophages, eosinophils, neutrophils, and mast cells (PMID: 26090498). CD30L interacts with its receptor, CD30, which is a cell surface protein expressed on a small subset of activated T and B lymphocytes, and a variety of lymphoid neoplasms, with the highest expression in classical Hodgkin lymphoma and anaplastic large cell lymphomas (PMID: 28885612). The CD30/CD30L signaling is involved in pleiotropic downstream effects including differentiation, cell survival and death, NFkB activation, and production of cytokines (PMID: 38534788).